1. Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial
- Author
-
Ford, Alexander C, primary, Wright-Hughes, Alexandra, additional, Alderson, Sarah L, additional, Ow, Pei-Loo, additional, Ridd, Matthew J, additional, Foy, Robbie, additional, Bianco, Gina, additional, Bishop, Felicity L, additional, Chaddock, Matthew, additional, Cook, Heather, additional, Cooper, Deborah, additional, Fernandez, Catherine, additional, Guthrie, Elspeth A, additional, Hartley, Suzanne, additional, Herbert, Amy, additional, Howdon, Daniel, additional, Muir, Delia P, additional, Nath, Taposhi, additional, Newman, Sonia, additional, Smith, Thomas, additional, Taylor, Christopher A, additional, Teasdale, Emma J, additional, Thornton, Ruth, additional, Farrin, Amanda J, additional, Everitt, Hazel A, additional, Ford, Alexander C., additional, Wright-Hughes, Alex, additional, Alderson, Sarah L., additional, Ridd, Matthew J., additional, Barratt, Maggie, additional, Bishop, Felicity L., additional, Brindle, Richard, additional, Brown, Sarah, additional, Christodoulou, Aimee, additional, Day, Florence, additional, Dowse, Aaron, additional, Durnell, Jill, additional, Emmerson, Jake, additional, Fellows, Alasdair, additional, Guthrie, Elspeth A., additional, Hindmarch, Damien, additional, Malik, Aminah, additional, Morris, Tom, additional, Muir, Delia P., additional, Longo, Roberta, additional, Lopes Goncalves Graca, Sandra, additional, Parker, Catriona, additional, Taylor, Christopher A., additional, Teasdale, Emma J., additional, Tubeuf, Sandy, additional, West, Amy, additional, Williamson, Emma-Jane, additional, Farrin, Amanda J., additional, and Everitt, Hazel A., additional
- Published
- 2023
- Full Text
- View/download PDF